Originally posted by Neuronix
Interesting. Duke and UChicago both claimed to have the highest grant score and Cornell has an increase in amount of funding? Confusing. But then again, this is what we have to put up with as people being fed small, subjectively chosen, amounts of objective information by people trying to sell their schools.
For those who have never heard how the NIH grant review system works, here's my quick attempt to explain it. Because this is a NIH grant, programs are reviewed once every five years and given a grant score, something like research grants. The NIH sends out this big site review team and takes into account lots of factors for writing their reviews.
When everything is done, the scores are used to decide which programs get more money, which stay the same, and which get less money or probation. Like a research grant, the higher your score, the more likely it is to get funded, depending on the research budget.
I wonder if I could get grant reviews by the FOIA. I can't see why that would be "classified" somehow that the public would not be able to get to.
Neuronix is fairly accurate in his description of the review process for training grants. My only quibble is that the priority scores given grants is inverted. That is, on a scale of 100 to 500, the lower the score the better. Also, the statement about site reviews was not entirely correct; site visit teams are now only sent out if the NIH has concerns about a program or if the program leadership has changed.
As far as the claims by Duke, Chicago, etc. that they have the best program according to the NIH, that is simply not true. The NIH does not have any sort of numeric ranking of programs by priority scores or by any other method. In general terms, a program that has a priority score of 150 is more meritorius than a program that has a score of 300, but it is debatable whether a 150 is better than a 160 or a 175. I do not know what the current payline is on NIGMS training grants (the payline is the cutoff for funding), but I believe that any score under 200 is bankable. These priority scores are subjective judgements, made over a period of 5 years by a group whose membership changes constantly. They are probably a little bit better than the figure skating judging at the Olympics, but they are by no means definitive.
Duke, Chicago, Cornell, etc., will all provide you with an opportunity to achieve you goal of becoming a physician-scientist. Cornell's achievement of receiving additional funding is substantial, given 1) the tight NIH training budget, 2) the fact that the program was on the rocks a decade ago and in danger of lapsing. Olaf Anderson has done a tremendous job in transforming this into a premiere program. (Nancy Andrews did a similar job at Harvard, taking over a program that was on probation and putting it back on track.) Still, you should not read too much into this. The passage that Habari quoted from the NIH's review of the Tri-Instutional Program is nearly verbatim to that given to my program. This demonstrates that either my program is as good as Cornell's, or that the NIH is as good at cutting & pasting text in grant reviews as students are in filling out MD/PhD applications.
In the end, you need to make an individual decision about which program will suit you best, regardless of what common wisdom, US News, grandma, or the false claims of NIH ranking say. If it turns out the University of Cincinnati MSTP is the best fit for you, you should go there, rather than taking a risk at being miserable at Duke for 7 or 8 years just because of US News or because the people at Duke make claims about nonexistent NIH rankings. As a MD/PhD, the world of academic medicine is wide open to you, regardless of whether your degree is from Duke, Cincinnati, Penn State or Stanford.